Azmil H. Abdul‐Rahim

Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial

Richard E. Thompson, Michael Rosenblum, Gayane Yenokyan et al. · The Lancet · 2019 · 899 citations · Full text

Medicine, Neurosurgery, Surgery +15

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

Sonia S. Anand, Jackie Bosch, John W. Eikelboom et al. · The Lancet · 2017 · 880 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

Stuart J. Connolly, John W. Eikelboom, Jackie Bosch et al. · The Lancet · 2017 · 756 citations · Full text

Medicine, Cardiology, Pharmacology +13

Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation

Maurizio Paciaroni, Giancarlo Agnelli, Nicola Falocci et al. · Stroke · 2015 · 281 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Surgical Performance Determines Functional Outcome Benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) Procedure

Issam A. Awad, Sean P. Polster, Julián Carrión‐Penagos et al. · Neurosurgery · 2019 · 144 citations · Full text

Medicine, Neurosurgery, Surgery +17